Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Burns Matteson Capital Management LLC

Burns Matteson Capital Management LLC increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.4% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 757 shares of the biotechnology company’s stock after purchasing an additional 25 shares during the quarter. Burns Matteson Capital Management LLC’s holdings in Axon Enterprise were worth $450,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Asset Dedication LLC grew its position in Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares in the last quarter. Bleakley Financial Group LLC grew its holdings in Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares in the last quarter. Insigneo Advisory Services LLC increased its stake in Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares during the period. Menard Financial Group LLC lifted its holdings in Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after buying an additional 24 shares in the last quarter. Finally, PFG Investments LLC boosted its position in Axon Enterprise by 0.6% in the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after buying an additional 25 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $679.24 on Monday. The company has a market cap of $51.79 billion, a P/E ratio of 175.51, a PEG ratio of 6.79 and a beta of 1.05. The business has a 50 day moving average of $623.43 and a two-hundred day moving average of $496.32. Axon Enterprise, Inc. has a 52 week low of $255.68 and a 52 week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 in the last 90 days. 6.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

AXON has been the topic of a number of analyst reports. JMP Securities boosted their price target on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 4th. The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $542.15.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.